ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Key Considerations for Disease Modifying Parkinson's Disease Trials
Key considerations for disease modifying parkinson's disease trials
How to use digital health in clinical trials to improve patient engagement
A thought leadership article discussing the positive outcomes of a unified patient experience.
Precision medicine: Overcoming cost challenges
Learn how the solutions are two-fold; requiring implementation of technologies to enhance treatment efficacy, coupled with the optimisation of value-based models.
New Unfoldings in Pharma Compliance
Discover strategies to navigate upcoming disruptions and highlighting best practice to ensure compliance for digital clinical trials in this media article.
Improving Pharma R&D Efficiency
This article explores the need for a holistic and integrated approach to improve clinical trial efficiencies.
Hybrid Study Designs & the Link Between RWE, Epidemiology
Read how hybrid study designs can be advantageous for the generation of RWE, providing a potential solution to the challenges presented by observational studies.
Integrated Technology Platform For Adaptive Clinical Trials
The new platform, ADDPLAN® neo combines modules from pre- existing technology for adaptive clinical trials
FDA Guidance on Communicating with Payers
Read more about significant provisions in recent FDA guidance documents and the key takeaways for manufacturers when sharing health economic data with payers
Digital Trials A Framework for Success
There is increasing interest in digital trials, that is the use of mHealth and mobile technology to capture insights outside the traditional clinical research setting
Challenges Associated with new EU MDR and IVDR
Vicki Anastasi, and Karen Hill, ICON, examine the key challenges associated with new EU MDR and IVDR.